February 2002
|Volume 14 Issue 2
Acute coronary syndromes, which include unstable angina (UA), non-Q wave myocardial infarction (NQWMI) and ST-segment elevation acute myocardial infarction (AMI), represent the most common diagnoses for admission of patients with cardiovascular disea…
Among patients with acute myocardial infarction (AMI), the efficacy of treatments that decrease mortality by coronary reperfusion and control of arrhythmia is dependent on time and access to acute medical care. Coronary reperfusion requires early adm…
Continued from previous page
Review of Primary PCI
Since the introduction of PTCA more than 20 years ago, technical advances and increased operator experience have contributed to a steady improvement in the success rate of this procedure. However, t…
In patients with ST-segment elevation acute myocardial infarction (AMI), several studies have examined the role of glycoprotein (GP) IIb/IIIa receptor inhibition as adjunctive pharmacotherapy for percutaneous coronary intervention (PCI) and as part o…
Platelets are now widely acknowledged as pivotal in the development of arterial thrombosis and its resultant acute ischemic coronary syndromes (ACS), including unstable angina (UA), non-Q wave myocardial infarction (NQWMI), ST-segment elevation acute…
Continued from previous page
PURSUIT. The PURSUIT trial was designed to evaluate eptifibatide as an adjunct to a broad spectrum of management strategies used to prevent death and MI in the 30 days following an urgent episode of UA or NQWMI. The 10,9…